This topic contains a solution. Click here to go to the answer

Author Question: GLP-1 agonists: 1. Directly bind to a receptor in the pancreatic beta cell 2. Have been approved ... (Read 83 times)

erika

  • Hero Member
  • *****
  • Posts: 522
GLP-1 agonists:
 
  1. Directly bind to a receptor in the pancreatic beta cell
  2. Have been approved for monotherapy
  3. Speed gastric emptying to decrease appetite
  4. Can be given orally once daily

Question 2

Avoid concurrent administration of exenatide with which of the following drugs?
 
  1. Digoxin
  2. Warfarin
  3. Lovastatin
  4. All of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jaaaaaaa

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

1

Answer to Question 2

4




erika

  • Member
  • Posts: 522
Reply 2 on: Jul 24, 2018
Great answer, keep it coming :)


Dominic

  • Member
  • Posts: 328
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library